PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
23.54
-0.26 (-1.09%)
At close: Nov 16, 2026, 4:00 PM EST
23.53
-0.01 (-0.04%)
Pre-market: Nov 17, 2026, 7:00 AM EST
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, PROCEPT BioRobotics stock has a consensus rating of "Hold" and an average price target of $22.75. The average 1-year stock price forecast is 3.36% lower than the current stock price, while the lowest is $16 (-32.03%) and the highest is $30 (+27.44%).
Price Target: $22.75 (-3.36%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for PROCEPT BioRobotics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 5 | 7 | 9 | 9 | 9 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Reiterates $21 → $24 | Hold | Reiterates | $21 → $24 | +1.95% | Nov 6, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Nov 6, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Nov 5, 2026 |
| Leerink Partners | Leerink Partners | Hold Reiterates $20 → $22 | Hold | Reiterates | $20 → $22 | -6.54% | Nov 5, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $28 | Buy | Reiterates | $28 | +18.95% | Nov 5, 2026 |
Financial Forecast
Revenue This Year
395.65M
from 308.05M
Increased by 28.44%
Revenue Next Year
474.85M
from 395.65M
Increased by 20.02%
EPS This Year
-1.72
from -1.72
EPS Next Year
-1.23
from -1.72
EPS and Forward PE are based on non-GAAP adjusted numbers.